Fox chase cancer center
Abington memorial hospital
Bryn mawr hospital
Hahnemann university hospital
Hospital of the university of pennsylvania
Lankenau medical center
Temple university hospital
Thomas jefferson university hospital
Fox Chase Cancer Center Onclgy
Prognostic value of biologic subtype and the 21-gene recurrence score relative to local recurrence after breast conservation treatment with radiation for early stage breast carcinoma: results from the Eastern Cooperative Oncology Group E2197 study.
Breast Cancer Res. Treat., Jul;134(2):683-92 (2012)
Four-week course of radiation for breast cancer using hypofractionated intensity modulated radiation therapy with an incorporated boost.
Int. J. Radiat. Oncol. Biol. Phys., Jun;68(2):347-53 (2007)
Concurrent doxorubicin plus docetaxel is not more effective than concurrent doxorubicin plus cyclophosphamide in operable breast cancer with 0 to 3 positive axillary nodes: North American Breast Cancer Intergroup Trial E 2197.
J. Clin. Oncol., Sep;26(25):4092-9 (2008)
Optimizing chemotherapy regimens for patients with early-stage breast cancer.
Clin. Breast Cancer., 10 Suppl 1:E8-15 (2010)
Impact of the radiation boost on outcomes after breast-conserving surgery and radiation.
Int. J. Radiat. Oncol. Biol. Phys., Sep;81(1):69-76 (2011)
Taxanes in the adjuvant treatment of breast cancer.
J Natl Compr Canc Netw., Apr;1(2):222-31 (2003)
Prognostic and predictive factors in early-stage breast cancer.
Oncologist., 9(6):606-16 (2004)
Controversies in adjuvant endocrine treatment of premenopausal women.
Clin. Breast Cancer., Feb;6 Suppl 2:S36-40 (2006)
Multiple drug resistance: biologic basis and clinical significance in renal-cell carcinoma.
Semin. Oncol., Feb;22(1):17-28 (1995)
Quantitative reverse transcriptase-polymerase chain reaction measured expression of MDR1 and MRP in primary breast carcinoma.
Clin. Cancer Res., Jun;4(6):1533-42 (1998)
Routine mammography is associated with earlier stage disease and greater eligibility for breast conservation in breast carcinoma patients age 40 years and older.
Cancer., Sep;98(5):918-25 (2003)
Medical management of early-stage breast cancer.
Curr Probl Cancer., 15(4):157-232 (1991)
Multidrug resistance in human cancer.
Crit. Rev. Oncol. Hematol., 12(3):243-53 (1992)
Peripheral blood stem cell transplant in breast cancer.
Semin. Oncol., Jun;22(3):238-49 (1995)